Effect of Liqi Huatan Quyu Formula (LHQF) on the Expression of Hepatic PPAR and CPT-Ⅰ in Rats with NASH

施军平,范建高,陈芝芸,何蓓晖,严茂祥,荀运浩
DOI: https://doi.org/10.3969/j.issn.1673-7717.2008.08.051
2008-01-01
Abstract:Objective:To validate the effect of LHQF on hepatic PPAR α,PPARγ and CPT-I expression of rats in order to approach potential mechanism of LHQF against NASH induced by high fat diet.Methods:50 male SD rats were randomly divided into the normal control group(10 rats),the model group(10 rats),the Pioglitazone group(10 rats),the LHQF high dose group(10 rats) and the LHQF low dose group(10 rats).Except for the normal control group which was raised by standard animal feeds,others were all raised by high fat feeds to make NASH model and administered by Pioglitazone,high dose LHQF and low dose LHQF for 12 weeks.Histopathological changes were evaluated in the liver,as were hepatic PPARα,PPARγ and CPT-I expression levels.The data were analyzed statistically.Results:In this NASH model,the histopathological showed increased fatty droplets within hepatocytes and liver inflammation,so were hepatic PPARγ expression levels,but the levels of PPARα and CPT-I mRNA expression were reduced.In the Pioglitazone group,the levels of hepatic PPARγ mRNA and protein were decreased.The expression of PPARα and CPT-I mRNA the LHQF high dose group and LHQF low dose group were enhanced compared with that in the model group.Compared with the Pioglitazone group,the levels of hepatic PPARα and CPT-I mRNA were enhanced remarkably.In addition,liver inflammation was improved evidently.Conclusion:LHQF can enhance obviously the gene expression of hepatic PPAR α and CPT-I,and depress markedly expression of hepatic PPAR γ,which was one of potential mechanism of LHQF against NASH.
What problem does this paper attempt to address?